David Phillip Guo, MD
Urology · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Guo’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A122619 · Current
Licensed to practise in California · since 2012 · expires 2028-03-31 · Harvard Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$16,804
Pharmacies billed $16,804 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
261 generic and fewer than 11 brand-name prescriptions · $16,804 in drug cost · 94 antibiotic prescriptions to 75 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 11 | $10,408 | $946 |
| Tamsulosin | 55 | $862 | $16 |
| Finasteride | 46 | $719 | $16 |
| Ciprofloxacin | 42 | $285 | $7 |
| Oxybutynin Chloride Er | 16 | $226 | $14 |
See all 7 drugs
| Myrbetriq | 11 | $10,408 | $946 |
| Tamsulosin | 55 | $862 | $16 |
| Finasteride | 46 | $719 | $16 |
| Ciprofloxacin | 42 | $285 | $7 |
| Oxybutynin Chloride Er | 16 | $226 | $14 |
| Cephalexin | 18 | $148 | $8 |
| Sulfamethoxazole-Trimethoprim | 17 | $108 | $6 |
Year by year
| 2024 | 279 | 172 | None | None | $16,804 |
| 2023 | 235 | 145 | None | 6% | $11,723 |
| 2022 | 238 | 138 | None | None | $5,228 |
| 2021 | 300 | 161 | None | None | $16,825 |
| 2020 | 224 | 141 | None | None | $11,427 |
| 2019 | 295 | 195 | None | None | $11,587 |
| 2018 | 54 | 39 | 0% (0) | None | $4,219 |
| 2017 | 60 | 47 | 58% (35) | None | $2,939 |
| 2016 | 46 | 41 | 87% (40) | 0% | $471 |
| 2015 | 82 | 55 | 54% (44) | 13% | $2,751 |
| 2014 | 45 | 23 | None | None | $1,307 |
| 2013 | 65 | 33 | 43% (28) | None | $2,465 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Myrbetriq | 11 | $5,135 | $467 |
| Finasteride | 41 | $632 | $15 |
| Tamsulosin | 44 | $611 | $14 |
| Ciprofloxacin | 32 | $239 | $7 |
| Sulfamethoxazole-Trimethoprim | 18 | $119 | $7 |
2022: 7 drugs
| Tamsulosin | 43 | $654 | $15 |
| Finasteride | 39 | $596 | $15 |
| Ciprofloxacin | 31 | $215 | $7 |
| Oxybutynin Chloride Er | 14 | $211 | $15 |
| Cephalexin | 15 | $127 | $8 |
| Sulfamethoxazole-Trimethoprim | 19 | $114 | $6 |
| Amoxicillin | 12 | $97 | $8 |
2021: 7 drugs
| Oxybutynin Chloride Er | 24 | $858 | $36 |
| Tamsulosin | 55 | $842 | $15 |
| Finasteride | 50 | $778 | $16 |
| Ciprofloxacin | 30 | $204 | $7 |
| Sulfamethoxazole-Trimethoprim | 21 | $134 | $6 |
| Cephalexin | 17 | $132 | $8 |
| Amoxicillin | 14 | $114 | $8 |
2020: 4 drugs
| Tamsulosin | 46 | $899 | $20 |
| Finasteride | 36 | $749 | $21 |
| Terazosin | 11 | $275 | $25 |
| Ciprofloxacin | 29 | $186 | $6 |
2019: 8 drugs
| Tamsulosin | 69 | $1,562 | $23 |
| Oxybutynin Chloride Er | 13 | $953 | $73 |
| Trospium Chloride | 14 | $650 | $46 |
| Finasteride | 32 | $630 | $20 |
| Bicalutamide | 17 | $209 | $12 |
| Ciprofloxacin | 32 | $196 | $6 |
| Sulfamethoxazole-Trimethoprim | 24 | $157 | $7 |
| Cephalexin | 13 | $101 | $8 |
2018: 2 drugs
| Testosterone Cypionate | 11 | $319 | $29 |
| Tamsulosin | 11 | $229 | $21 |
2017: 1 drug
| Hydrocodone-Acetaminophen | 28 | $370 | $13 |
2016: 1 drug
| Hydrocodone-Acetaminophen | 38 | $387 | $10 |
2015: 1 drug
| Hydrocodone-Acetaminophen | 35 | $380 | $11 |
2013: 1 drug
| Hydrocodone-Acetaminophen | 21 | $152 | $7 |
Money from drug and device companies
$50 in 2025
A payment is not proof that care is biased.
| Myriad Genetic Laboratories | Prolaris | $50 | 1 payment
|
See the published payment
| Myriad Genetic Laboratories | Meals · 2025-04-26 | Prolaris | $50 |
Professional record
- NPI
- 1598054991
- Licence
- CA A122619California A122619: Current · expires 2028-03-31
- Trained
- Harvard Medical School, 2011
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Urology (208800000X); Student in a training program (390200000X)
- Mailing address
- 710 Lawrence Expy Dept 448, Santa Clara, CA, 95051
- NPI first listed
- 2011-04-06
- NPI last updated
- 2021-12-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Palo Alto, CA, 94305
This office lists an electronic records connection.